JLQ-15177-96609 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-23
Dose 1 — Pfizer-BioNTech
2021-01-12
Registered in v-safe
2021-01-12
Dose 2 — Pfizer-BioNTech
2021-01-12
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-14
Survey response — days 1–6 daily, dose 2
MedDRA: Confusional state, Dizziness, Nausea, Salivary hypersecretion — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities

Free text: Extreme nausea with mouth watering. Mild dizziness and confusion

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-14
Report sent to call center — days 1–6 daily, dose 2
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-01-15
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Nausea

Adult check-in
2021-01-16
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Nausea, Vomiting · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-01-16
Report sent to call center — days 1–6 daily, dose 2
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-01-17
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-18
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Nausea

Adult check-in
2021-01-21
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-01-26
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-02
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-13
Call 1 — Left Voicemail
2021-02-23
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-13
Survey response — 3 months, dose 2
MedDRA: Dizziness, Hyperhidrosis — Feeling: Good · Be unable to do your normal daily activities

Free text: Dizziness and severe light headed with the feeling of passing out, with body sweats.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-13
Report sent to call center — 3 months, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-07-13
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-01-12
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-23	Pfizer-BioNTech
2	2021-01-12	Pfizer-BioNTech

Call center

3 call center cases

2 unsuccessful · 1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 2 — days 1–6 daily, dose 2

2021-01-14

Systemic reaction (other): Extreme nausea with mouth watering. Mild dizziness and confusion

Release 7 — 3 months, dose 2

2021-04-13

Symptoms: Dizziness and severe light headed with the feeling of passing out, with body sweats.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Dizziness	✓	✓	✓
SD	Hyperhidrosis	✓	✓	✓
SRO	Confusional state	✓	✓	✓
SRO	Dizziness	✓	✓	✓
SRO	Nausea	✓	✓	✓
SRO	Salivary hypersecretion	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release